A detailed history of Quent Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Quent Capital, LLC holds 1,387 shares of AZN stock, worth $87,921. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,387
Previous 1,352 2.59%
Holding current value
$87,921
Previous $105,000 2.86%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$76.67 - $87.62 $2,683 - $3,066
35 Added 2.59%
1,387 $108,000
Q2 2024

Jul 08, 2024

BUY
$66.81 - $80.83 $1,202 - $1,454
18 Added 1.35%
1,352 $105,000
Q1 2024

Jun 28, 2024

SELL
$61.03 - $69.57 $61 - $69
-1 Reduced 0.07%
1,334 $90,000
Q1 2024

May 02, 2024

BUY
$61.03 - $69.57 $25,022 - $28,523
410 Added 44.32%
1,335 $90,000
Q4 2023

Jun 14, 2024

BUY
$61.89 - $69.28 $11,387 - $12,747
184 Added 24.83%
925 $62,000
Q4 2023

Jan 19, 2024

BUY
$61.89 - $69.28 $11,387 - $12,747
184 Added 24.83%
925 $62,000
Q3 2023

Jun 14, 2024

BUY
$64.85 - $71.7 $64 - $71
1 Added 0.14%
741 $50,000
Q3 2023

Oct 10, 2023

BUY
$64.85 - $71.7 $64 - $71
1 Added 0.14%
741 $50,000
Q2 2023

Jun 14, 2024

BUY
$69.91 - $75.81 $1,607 - $1,743
23 Added 3.21%
740 $52,000
Q2 2023

Jul 10, 2023

BUY
$69.91 - $75.81 $1,607 - $1,743
23 Added 3.21%
740 $52,000
Q1 2023

Jun 14, 2024

SELL
$63.15 - $71.6 $39,026 - $44,248
-618 Reduced 46.29%
717 $49,000
Q1 2023

Apr 05, 2023

BUY
$63.15 - $71.6 $126 - $143
2 Added 0.28%
717 $49,000
Q4 2022

Jan 19, 2023

SELL
$54.21 - $70.44 $15,883 - $20,638
-293 Reduced 29.07%
715 $0
Q2 2022

Aug 08, 2022

BUY
$59.26 - $71.14 $4,266 - $5,122
72 Added 7.69%
1,008 $67,000
Q1 2022

May 12, 2022

BUY
$55.72 - $67.12 $22,288 - $26,848
400 Added 74.63%
936 $62,000
Q4 2021

Feb 28, 2022

BUY
$54.02 - $63.83 $28,954 - $34,212
536 New
536 $31,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.